Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines

Clinical trial NCT02184988 · COMPLETED

Trial details

NCT number: NCT02184988
Sponsor: Evolus, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glabellar Frown Lines

Start date: 2014-08-01
Primary completion: 2015-12-01
Enrollment: 352

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.